Tango Therapeutics
Boston, United States
Julie Shields is a Scientist I in the discovery biology group at Tango Therapeutics. Her work focuses on identifying novel synthetic lethal targets for the treatment of cancer and supporting drug discovery efforts. Prior to her current position, Julie was a senior associate scientist at Pfizer working in the regulated bioanalytical assay develoment group to support the large molecule portfolio. She earned her Bachelor of Science (BS) and Master of Engineering (MEng) in biomedical engineering from Cornell University.